High Cholesterol, Diet-Proof. Your Genes May Be the Real Problem.

Your cells need to pull LDL cholesterol out of the bloodstream so they can use it for building cell membranes and making hormones. The LDL receptor is the protein that sits on the surface of your liver cells and grabs LDL particles from the blood, pulling them inside. Without working LDL receptors, your cells can’t grab the cholesterol they need, and the LDL just keeps circulating.

LDLR variants cause familial hypercholesterolemia in roughly 85% of cases. There are over 1,000 different pathogenic variants in this gene, ranging from complete loss of function to partial reduction in receptor activity. The severity of your cholesterol elevation depends on whether you inherited one variant (heterozygous) or two (homozygous). People with one variant typically have LDL levels of 300-500 mg/dL. People with two variants can have LDL above 600 mg/dL and often show signs of early heart disease before age 30.

If you carry an LDLR variant, your liver is essentially unable to perform its primary cholesterol-clearing function. No amount of diet will fix this. Your body is behaving exactly as it’s genetically programmed to. Standard statins lower LDL by 20-50%, but your LDL baseline is so high that you still end up with a dangerously elevated level even with maximum-dose statin therapy.

Every LDL particle in your blood is wrapped in a coating protein called apolipoprotein B, or ApoB. This protein is the ‘key’ that lets the LDL receptor recognize and bind to the cholesterol particle. Without proper ApoB, even if your LDL receptors are working perfectly, the receptors can’t grab the particles.

APOB variants cause familial hypercholesterolemia in roughly 5% of FH cases. The most common variant is R3527Q, a defect that prevents ApoB from binding effectively to the LDL receptor. People with this variant have LDL levels typically in the 300-400 mg/dL range. The key difference from LDLR variants is that your receptors are fine, but your LDL particles are defective and can’t be recognized.

If you carry an APOB variant, your body is making LDL particles that your liver literally cannot recognize and remove. It’s as if you’re sending mail with the wrong address; the postal worker (your LDL receptor) is standing by ready to work, but the envelope (your LDL particle) is labeled incorrectly. Your LDL doesn’t get delivered into the cell, so it stays in circulation.

Your liver cells make LDL receptors and display them on their surface to grab cholesterol out of the blood. But those receptors don’t last forever. They get recycled and replaced regularly. PCSK9 is a protein that degrades LDL receptors, essentially telling your body to throw them away. Normally, this process is tightly regulated so you maintain enough receptors to clear cholesterol efficiently.

Gain-of-function PCSK9 variants are found in roughly 1-3% of the population. These variants cause your body to degrade LDL receptors faster than normal, leaving you with fewer receptors available to clear LDL. People with gain-of-function PCSK9 variants typically have LDL levels in the 250-400 mg/dL range. The ironic part is that this is one of the few FH forms that modern medicine can target directly.

If you carry a gain-of-function PCSK9 variant, your body is essentially destroying your own LDL receptors faster than you can use them. You’re wearing down your cholesterol-clearing machinery prematurely. Standard statins actually make this problem worse because statins trigger your body to make more PCSK9 to compensate, leading to even more receptor degradation.

Apolipoprotein E, or ApoE, is a protein that helps your liver recognize and remove remnant particles left behind after other parts of your body have used triglycerides. Your body makes three versions of ApoE: e2, e3, and e4. You inherit one from each parent, creating six possible combinations. These variants affect how well your liver clears cholesterol-rich particles from circulation.

The e4 variant, carried by roughly 25% of people with European ancestry, reduces your liver’s ability to clear LDL and increases overall cardiovascular risk. People with one e4 allele have modestly higher LDL levels; people with two e4 alleles have significantly elevated levels and much higher heart disease risk. The e4 variant is so strong that it’s one of the few genetic risk factors for both early heart disease and Alzheimer’s disease.

If you carry the APOE e4 variant, your liver is less efficient at clearing cholesterol particles from your blood. This compounds other risk factors. If you also have an LDLR variant, your e4 status makes the problem worse. If you have high blood pressure or any other cardiovascular risk factor, e4 amplifies that risk. Your genes are stacking against you.

Your blood contains multiple types of lipid transport particles: LDL (bad), HDL (good), and others. CETP is a protein that shuttles cholesterol between these particles, moving cholesterol from HDL to LDL and triglyceride-rich particles. Normally, this happens at a moderate rate. Variants in CETP change how fast this shuttle runs, which affects the composition of both your HDL and LDL particles.

CETP variants like TaqIB and I405V are carried by roughly 40% of the population. These variants reduce CETP activity, which sounds good (less cholesterol moving from good HDL to bad LDL), but the reality is more complex. Reduced CETP activity does increase HDL cholesterol, which is protective. However, it can also make your LDL particles smaller and denser, which may actually be more atherogenic (more likely to stick to artery walls and cause plaques).

If you carry a CETP variant, your cholesterol metabolism is altered in ways that simple LDL numbers don’t capture. You might have high HDL but still have a dangerous pattern of small, dense LDL particles that standard cholesterol tests won’t flag. Your ‘good’ cholesterol number looks great, but your actual cardiovascular risk is being masked.

Lipoprotein(a), or Lp(a), is a type of cholesterol particle that’s particularly prone to getting stuck in artery walls and triggering inflammation and plaque formation. Unlike LDL cholesterol, which is influenced heavily by diet and behavior, Lp(a) is almost entirely genetically determined. Your Lp(a) level is set by your genes and will remain roughly the same throughout your life, regardless of how much you exercise or change your diet.

Roughly 20% of the population carries genetic variants that produce high Lp(a) levels. People with high Lp(a) have 2-4x higher risk of heart attack and stroke compared to people with low Lp(a), even if their LDL cholesterol is controlled. Lp(a) is particularly dangerous because it combines the cholesterol-carrying part of LDL with an inflammatory protein (apo(a)) that your immune system recognizes as foreign, triggering extra inflammation in your arteries.

If you carry a high Lp(a) variant, you have a genetically predetermined cardiovascular risk that diet and statins cannot eliminate. Most people don’t know their Lp(a) level because it’s not measured in standard cholesterol panels. You could have LDL perfectly controlled on maximum-dose statins and STILL have extremely high cardiovascular risk if your Lp(a) is elevated. Standard cholesterol treatment misses this entirely.